Nicotinell Tts 20

Nicotine, the active ingredient in Nicotinell TTS 20, is a nicotine replacement therapy presented as a 20 mg transdermal patch for transdermal use. It aids smoking cessation and relieves nicotine withdrawal symptoms in adult smokers seeking to quit.

GNH USA supplies Nicotinell TTS 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell TTS 20, a nicotine replacement therapy, is used in the management of nicotine dependence.

- Smoking cessation: helps adult smokers gradually reduce nicotine intake and quit smoking. - Nicotine withdrawal relief: alleviates cravings, irritability and other withdrawal symptoms during quit attempts. - Relapse prevention: supports maintenance of abstinence after successful cessation.

Common Side Effects: - Skin irritation at the application site: redness, itching or mild rash. - Sleep disturbance: difficulty falling asleep or staying asleep. - Vivid dreams or unusual dreams. - Nausea or mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives or severe rash. - Hypotension or dizziness, especially when standing quickly. - Chest pain or palpitations indicating possible cardiovascular stress.

Before using Nicotinell TTS 20, consider the following precautions. - Cardiovascular assessment: evaluate recent heart attack or unstable angina. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously. - Skin condition: do not apply to damaged, irritated or infected skin. - Monitoring: watch for signs of excessive nicotine exposure such as rapid heartbeat. - Store at room temperature: keep in the original pouch, protect from moisture and direct heat.

Nicotinell TTS 20 may interact with other medicines or substances.

Major Interactions (Avoid): - Other nicotine-containing products: risk of nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): may increase cardiovascular effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Antidepressants (SSRIs, SNRIs): may heighten side‑effect profile. - Alcohol: can amplify dizziness or hypotension.